Effectiveness and safety of subcutaneous immunotherapy with standardized house dust mite extract for patients under the age of 5 years: A prospective cohort study
Published: 2021 Received: January 03, 2021Released on J-STAGE: October 13, 2021Accepted: April 23, 2021
Advance online publication: -
Revised: April 06, 2021